Clinical Trial Update: Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating HLX10 in combination with HLX07 for advanced head and neck tumors is ongoing, with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• HLX07 (HLX07)
• HLX10

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN